Patients With Locally Recurrent Resectable Head and Neck Squamous Cell Carcinoma

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Patients With Locally Recurrent Resectable Head and Neck Squamous Cell Carcinoma trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (2 shown)

Active — Not RecruitingPhase 2

NCT05586100

Neoadjuvant and Adjuvant Toripalimab and Cetuximab in Patients With Recurrent, Resectable Squamous Cell Carcinoma of Hea…

This study is the first clinical study of Neoadjuvant and Adjuvant treatment of head and neck squamous cell carcinoma with drugs targeting EGFR signaling pathwa…

China52 participantsStarted 2022-10-13

Treatment: Toripalimab+cetuximab

TerminatedPhase 1

NCT04588038

NT-I7 for the Treatment of Recurrent Squamous Cell Carcinoma of Head and Neck Undergoing Surgery

This phase I trial evaluates the side effects of NT-I7 in treating patients with squamous cell carcinoma of head and neck that has come back (recurrent) who are…

United States4 participantsStarted 2021-03-12

Treatment: Efineptakin alfa